Overview

A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)

Status:
Completed

Trial end date:
2012-07-02

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT) stress myocardial perfusion imaging (MPI) with regadenoson in order to detect the presence or absence of reversible defects.

Phase:

Phase 2

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Regadenoson
Technetium Tc 99m Sestamibi